b
b

Mission

The Center of Computational Imaging and Personalized Diagnostics (CCIPD) at Case Western Reserve University is involved in various different aspects of developing, evaluating and applying novel quantitative image analysis, computer vision, signal processing, segmentation, multi-modal co-registration tools, pattern recognition, and machine learning tools for disease diagnosis, prognosis, and theragnosis in the context of breast, prostate, head and neck, and brain tumors as well as epilepsy and carotid plaque. Our group is also exploring the utility of these methods in studying correlations of disease markers across multiple scales, modalities, and functionalities -- from gene and protein expression to spectroscopy to digital pathology and to multi-parametric MRI.

Sign up for the CCIPD newsletter here!


Facebook Live Stream with Anant

Latest News:

Wed, 2021-08-18 12:11

Please join us for a virtual Machine Learning Working Group Meeting on August 23rd, from 12-1pm EST. Greeshma Agasthya, PhD, Research Scientist in the Advanced Computing for Health Sciences Section at Oak Ridge National Lab will be presenting “Machine learning and deep learning-based time series analysis for early metastatic prostate cancer detection.”
 
Abstract: Prostate cancer (PCa) is the second most common cancer among men in the United States. It was estimated that there were 191,930 new PCa cases in 2020 in USA. A 2018 study showed an increasing...

Fri, 2021-08-06 12:44

CCIPD researchers have used Artificial Intelligence (AI) to identify new biomarkers for breast cancer that can predict whether the cancer will return after treatment. Furthermore, this study helped to identify which biomarkers can be identified from routinely acquired tissue biopsy samples of early-stage breast cancer. The key to that initial determination is collagen, a common protein found throughout the body, including in breast tissue. 

For more information, read the full story in CWRU’s...

Fri, 2021-07-30 14:59

Dr.Anant Madabhushi is named a Showstopper on The Pathologist’s 2021 Power List. This list celebrates 100 influential figures, thought leaders, and opinion shapers in pathology and laboratory medicine. Dr. Madabhushi was also named to the Power List in 2019 and 2020. 

For more information read more about this placement on The...

Thu, 2021-07-29 15:01

A CCIPD article is among the Top 10% Most Cited PLOS ONE papers published in 2018. Congratulations to CCIPD authors Andrew Janowczyk, PhD and Anant Madabhushi, PhD on this recognition of their paper titled, “A deep-learning classifier identifies patients with clinical heart failure using whole-slide images of H&E tissue.” As of the time of recording, the article has been cited 49 times and counting!

Further congratulations to authors Jeffery Nirschl (first author), Eliot G. Peyster, Renee Frank, Kenneth...

Mon, 2021-07-26 15:01

The four-year, $2.95 million NIH grant will be used to fund a research consortium exploring how imaging can be used to predict the risk of atrial fibrillation recurrence. The study will use Artificial Intelligence to develop and validate a new risk prediction tool. 

Read more about this grant from CWRU’s The Daily.